Generic

Mebhydrolin Napadisylate

Indications

Allergic diseases or symptoms, such as urticaria, pruritus of various origin, eczema, drug rash, allergic dermatitis, hay fever, vasomotor rhinitis, asthma and other allergic reactions.

Pharmacology

Mebhydroline reduces or eliminates the main effects of histamine in the body by blocking histamine receptors.

Dosage & Administration

Adults and children over 10 years : 2-6 tablets daily in divided doses.

Children : 5 – 10 years : 2 – 4 tablets daily in divided doses.

2 – 5 years : 1 – 3 tablets daily in divided doses.

Up to 2 years : 1 – 2 tablets daily in divided doses.

Mebolin® may be swallowed during or immediately after meals. For children Mebolin® may be crashed and mixed with food.

Interaction

Mebhydroline can potentiate the effects of atropine and tricyclic antidepressants. It can mask the warning signs of damage caused by ototoxic drugs.

Contraindications

Patients should be advised not to use CNS depressants or alcohol concomitantly with Mebhydrolin. Mebhy-drolin should not be administered to patients in whom agranulocytosis or neutropenia have been reported previously.

Side Effects

Fatigue, dizziness, hypotension, muscle weakness, nausea, vomiting, diarrhea or constipation, upper abdominal pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dry mouth, chest tightness, tingling, sedation, drowsiness, etc. May cause.

Pregnancy & Lactation

The safety during pregnancy and breastfeeding has not been determined.

Precautions & Warnings

This substance may cause drowsiness. If affected, avoid driving or operating machinery and alcoholic beverages.

Therapeutic Class

Sedating Anti-histamine

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Pharmaceutical Name

ACME Laboratories Ltd.